153 related articles for article (PubMed ID: 25573285)
21. Gefitinib enhances the efficacy of photodynamic therapy using 5-aminolevulinic acid in malignant brain tumor cells.
Sun W; Kajimoto Y; Inoue H; Miyatake S; Ishikawa T; Kuroiwa T
Photodiagnosis Photodyn Ther; 2013 Feb; 10(1):42-50. PubMed ID: 23465372
[TBL] [Abstract][Full Text] [Related]
22. 5-Aminolevulinic-acid-mediated Photodynamic Diagnosis Enhances the Detection of Peritoneal Metastases in Biliary Tract Cancer in Mice.
Kushibiki T; Noji T; Ebihara Y; Hontani K; Ono M; Kuwabara S; Nakamura T; Tsuchikawa T; Okamura K; Ishizuka M; Hirano S
In Vivo; 2017; 31(5):905-908. PubMed ID: 28882957
[TBL] [Abstract][Full Text] [Related]
23. Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid.
Juzeniene A; Iani V; Moan J
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):538-45. PubMed ID: 24284108
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of the bactericidal effects of 5-aminolevulinic acid with blue and red light on Propionibacterium acnes.
Choi MS; Yun SJ; Beom HJ; Park HR; Lee JB
J Dermatol; 2011 Jul; 38(7):661-6. PubMed ID: 21352326
[TBL] [Abstract][Full Text] [Related]
25. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
Palasuberniam P; Yang X; Kraus D; Jones P; Myers KA; Chen B
Sci Rep; 2015 Aug; 5():13298. PubMed ID: 26282350
[TBL] [Abstract][Full Text] [Related]
26. Oxygen Availability for Porphyrin Biosynthesis Enzymes Determines the Production of Protoporphyrin IX (PpIX) during Hypoxia.
Otsuka S; Matsumoto K; Nakajima M; Tanaka T; Ogura S
PLoS One; 2015; 10(12):e0146026. PubMed ID: 26717566
[TBL] [Abstract][Full Text] [Related]
27. The role of ABCG2 and ABCB6 in porphyrin metabolism and cell survival.
Krishnamurthy P; Schuetz JD
Curr Pharm Biotechnol; 2011 Apr; 12(4):647-55. PubMed ID: 21118089
[TBL] [Abstract][Full Text] [Related]
28. Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy.
Ishizuka M; Abe F; Sano Y; Takahashi K; Inoue K; Nakajima M; Kohda T; Komatsu N; Ogura S; Tanaka T
Int Immunopharmacol; 2011 Mar; 11(3):358-65. PubMed ID: 21144919
[TBL] [Abstract][Full Text] [Related]
29. Nrf2-dependent induction of human ABC transporter ABCG2 and heme oxygenase-1 in HepG2 cells by photoactivation of porphyrins: biochemical implications for cancer cell response to photodynamic therapy.
Hagiya Y; Adachi T; Ogura S; An R; Tamura A; Nakagawa H; Okura I; Mochizuki T; Ishikawa T
J Exp Ther Oncol; 2008; 7(2):153-67. PubMed ID: 18771089
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic effects of 5-aminolevulinic acid and its hexylester on several cell lines.
Wu SM; Ren QG; Zhou MO; Wei Y; Chen JY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):655-60. PubMed ID: 12883637
[TBL] [Abstract][Full Text] [Related]
31. Neurotransmitter transporter family including SLC6A6 and SLC6A13 contributes to the 5-aminolevulinic acid (ALA)-induced accumulation of protoporphyrin IX and photodamage, through uptake of ALA by cancerous cells.
Tran TT; Mu A; Adachi Y; Adachi Y; Taketani S
Photochem Photobiol; 2014; 90(5):1136-43. PubMed ID: 24842606
[TBL] [Abstract][Full Text] [Related]
32. The effect of iron ion on the specificity of photodynamic therapy with 5-aminolevulinic acid.
Hayashi M; Fukuhara H; Inoue K; Shuin T; Hagiya Y; Nakajima M; Tanaka T; Ogura S
PLoS One; 2015; 10(3):e0122351. PubMed ID: 25822972
[TBL] [Abstract][Full Text] [Related]
33. Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions.
Dysart JS; Patterson MS
Photochem Photobiol Sci; 2006 Jan; 5(1):73-81. PubMed ID: 16395430
[TBL] [Abstract][Full Text] [Related]
34. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
35. Human ABCB6 localizes to both the outer mitochondrial membrane and the plasma membrane.
Paterson JK; Shukla S; Black CM; Tachiwada T; Garfield S; Wincovitch S; Ernst DN; Agadir A; Li X; Ambudkar SV; Szakacs G; Akiyama S; Gottesman MM
Biochemistry; 2007 Aug; 46(33):9443-52. PubMed ID: 17661442
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin.
Ohgari Y; Nakayasu Y; Kitajima S; Sawamoto M; Mori H; Shimokawa O; Matsui H; Taketani S
Biochem Pharmacol; 2005 Dec; 71(1-2):42-9. PubMed ID: 16288996
[TBL] [Abstract][Full Text] [Related]
37. Porphyrins as urinary biomarkers for bladder cancer after 5-aminolevulinic acid (ALA) administration: the potential of photodynamic screening for tumors.
Inoue K; Ota U; Ishizuka M; Kawada C; Fukuhara H; Shuin T; Okura I; Tanaka T; Ogura S
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):484-9. PubMed ID: 24284101
[TBL] [Abstract][Full Text] [Related]
38. Low-dose arsenic trioxide enhances 5-aminolevulinic acid-induced PpIX accumulation and efficacy of photodynamic therapy in human glioma.
Wang C; Chen X; Wu J; Liu H; Ji Z; Shi H; Gao C; Han D; Wang L; Liu Y; Yang G; Fu C; Li H; Zhang D; Liu Z; Li X; Yin F; Zhao S
J Photochem Photobiol B; 2013 Oct; 127():61-7. PubMed ID: 23962849
[TBL] [Abstract][Full Text] [Related]
39. Preclinical characterization of 5-amino-4-oxo-[6-11C]hexanoic acid as an imaging probe to estimate protoporphyrin IX accumulation induced by exogenous aminolevulinic acid.
Suzuki C; Tsuji AB; Kato K; Kikuchi T; Sudo H; Okada M; Sugyo A; Zhang MR; Arano Y; Saga T
J Nucl Med; 2014 Oct; 55(10):1671-7. PubMed ID: 25125482
[TBL] [Abstract][Full Text] [Related]
40. Aminolevulinic acid derivatives-based photodynamic therapy in human intra- and extrahepatic cholangiocarcinoma cells.
Chung CW; Kim CH; Lee HM; Kim DH; Kwak TW; Chung KD; Jeong YI; Kang DH
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):503-10. PubMed ID: 23429232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
